Issue 12, 2018

Drug and chemical induced photosensitivity from a clinical perspective

Abstract

Drug photosensitivity is a relatively common occurrence and a range of mechanisms may be involved. Some of these mechanisms will be discussed, including the most common, that of drug phototoxicity. Different types of photosensitivity are addressed with respect to clinical presentation, mechanisms and additionally the contribution to our understanding through clinically directed investigations and regulatory requirements. Repeated controlled therapeutic use of drug phototoxicity, with psoralen-UVA (PUVA) photochemotherapy and photodynamic therapy (PDT) will also be discussed. Finally, the potential for drug-induced photocarcinogenesis will also be covered.

Graphical abstract: Drug and chemical induced photosensitivity from a clinical perspective

Article information

Article type
Perspective
Submitted
25 ربيع الثاني 1439
Accepted
29 ذو الحجة 1439
First published
30 ذو الحجة 1439

Photochem. Photobiol. Sci., 2018,17, 1885-1903

Drug and chemical induced photosensitivity from a clinical perspective

S. Ibbotson, Photochem. Photobiol. Sci., 2018, 17, 1885 DOI: 10.1039/C8PP00011E

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements